Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01 – HDBuzz

Huntington’s disease research news.

In plain language. Written by scientists.
For the global HD community.

HDBuzz Trial Tracker

Initial Phase 1 clinical data from ALN-HTT02

Alnylam Pharmaceuticals

Expected: Q4 2026

Phase 3 trial of SOM3355 expected to begin

SOM Biotech

Expected: Q4 2026

Regulatory updates on AMT-130 following US and UK submissions

uniQure

Expected: Not disclosed

Show 8 more Show less

Update on plans for a Phase 2/3 study of WVE-003

Wave Life Sciences

Expected: Not disclosed

PRECISE-HD Phase 3 trial of pridopidine begins recruitment

Prilenia-Ferrer

Expected: N/A

Updates from the ongoing Phase 3 INVEST-HD trial of votoplam

Novartis/PTC Therapeutics

Expected: Not disclosed

Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01

University of California, Irvine

Expected: Not disclosed

Further update from the Phase 1/2a trial of VO659

Vico Therapeutics

Expected: Not disclosed

Updates from the Phase 1/2 trial of RG6662 (SPK-10001) gene therapy

Roche

Expected: Not disclosed

Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515

Skyhawk Therapeutics

Expected: Not disclosed

Updates from the Phase 1 INSIGHTT trial of SRP-1005

Sarepta Therapeutics

Expected: Not disclosed